Jim Simons’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.39M Buy
3,259,738
+48,800
+2% +$114K 0.01% 1223
2025
Q4
$8.7M Sell
3,210,938
-258,400
-7% -$848K 0.01% 989
2025
Q3
$14.7M Sell
3,469,338
-129,100
-4% -$568K 0.02% 883
2025
Q2
$17.9M Buy
3,598,438
+587,400
+20% +$2.55M 0.02% 761
2025
Q1
$13.3M Buy
3,011,038
+129,800
+5% +$609K 0.02% 857
2024
Q4
$13.4M Sell
2,881,238
-106,000
-4% -$583K 0.02% 836
2024
Q3
$20.7M Buy
2,987,238
+41,000
+1% +$322K 0.03% 643
2024
Q2
$23M Sell
2,946,238
-129,800
-4% -$961K 0.04% 539
2024
Q1
$21.8M Buy
3,076,038
+99,139
+3% +$656K 0.03% 593
2023
Q4
$19.9M Buy
2,976,899
+238,761
+9% +$1.34M 0.03% 619
2023
Q3
$15.4M Buy
2,738,138
+240,016
+10% +$1.6M 0.03% 687
2023
Q2
$13.8M Buy
2,498,122
+250,800
+11% +$1.35M 0.02% 862
2023
Q1
$14M Buy
2,247,322
+340,100
+18% +$1.9M 0.02% 907
2022
Q4
$8.89M Sell
1,907,222
-314,400
-14% -$1.55M 0.01% 1159
2022
Q3
$10.4M Sell
2,221,622
-1,024,000
-32% -$6.46M 0.01% 1010
2022
Q2
$19.2M Buy
3,245,622
+2,859,300
+740% +$31.8M 0.02% 753
2022
Q1
$7.47M Buy
386,322
+305,700
+379% +$7.01M 0.01% 1322
2021
Q4
$2.63M Buy
+80,622
New +$3.24M ﹤0.01% 1940

Other funds holding GDRX

Jim Simons's GDRX Position: Q1 2026 in Review

Jim Simons increased its GoodRx Holdings (GDRX) stake by 1.5% in Q1 2026, buying an estimated $114K and bringing the position to 3,259,738 shares worth $6.39M. The position accounts for 0.01% of the portfolio, ranked #1223.

Jim Simons first reported a position in GDRX in Q4 2021 and has held it in 18 quarters since. The position peaked at $23M in Q2 2024. 175 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Jim Simons held 3,259,738 shares of GoodRx Holdings worth $6.39M as of Q1 2026.
  • Jim Simons bought 48,800 GoodRx Holdings shares in Q1 2026, an estimated $114K.
  • GoodRx Holdings made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1223 holding.
  • Jim Simons first reported a position in GoodRx Holdings in Q4 2021 and has held it in 18 quarters since.
  • Jim Simons's GoodRx Holdings position peaked at $23M in Q2 2024.
  • 175 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.